Close Menu

This story has been updated to include comments from Bio-Rad Laboratories.

NEW YORK – A US appeals court has lifted a permanent injunction against two products from 10x Genomics that a jury had found infringed patents held by Bio-Rad Laboratories: the Chromium Single-Cell CNV Solution and the discontinued Linked-Reads assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.